← Sites
St. Brigid University Hospital
IE
PI: Dr. C. Nolan
activated
KRI 0.2
Patients
3
Active (enrolled/consented)
2
Withdrawn
0
Serious AEs
1
Open QA findings
1
Aged data queries
0
Studies & contracts total budget 184000.00 USD
GAL-001: Adaptive Phase II in Refractory Melanoma
Phase II
study active
contract executed
184000 USD
Patients first 3
| Ref | Status | Consented | Study |
|---|---|---|---|
| GAL001-004 | enrolled | 2026-07-08 | GAL-001: Adaptive Phase II in Refractory Melanoma |
| GAL001-005 | consented | 2026-08-06 | GAL-001: Adaptive Phase II in Refractory Melanoma |
| GAL001-006 | screened | GAL-001: Adaptive Phase II in Refractory Melanoma |
Luna participants (2)
Safety 2 AEs · 1 serious
serious
GAL001-004
under_review
Grade 3 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2024-11-11 (study day 469); relationship: not assessed; serious criteria: hospitalization
QA findings 1 open
open
major
GCP
Two informed consent forms missing investigator countersignature date.
Monitoring visits (0)
No visits recorded.
Payments (0)
No payments on file.